Oxipital AI Closes Series A
Oxipital AI raises a Series A round led by SAS Private Equities and Scale Venture Partners to scale its AI vision platform for manufacturing.
Oxipital AI Closes Series A
Oxipital AI, based in Bedford, Massachusetts, is a software company that provides the V-CORTX platform, a synthetic AI vision solution designed for high-variability manufacturing environments. The company recently announced the successful close of its Series A financing round to accelerate the deployment of its AI-powered manufacturing solutions.
Investors
The round was co-led by SAS Private Equities and Scale Venture Partners, with participation from Material Impact and other existing shareholders.
Oxipital AI Use of Funds
The company plans to use the new capital to accelerate the deployment of its V-CORTX platform and scale its operations to meet growing demand in the manufacturing sector.
About Oxipital AI
Founded in the Greater Boston area, Oxipital AI develops V-CORTX, a synthetic visual intelligence platform. The platform enables conventional automation systems to observe, understand, and act with human-level performance in complex production environments, focusing on quality control, throughput optimization, and foreign material detection.
Funding Details
Company Website: https://oxipitalai.com
Company: Oxipital AI
Round: Series A
Funding Date: July 8, 2026
Lead Investor: SAS Private Equities, Scale Venture Partners
Additional Investors: Material Impact
Company Website: www.OxipitalAI.com
Software Category: Artificial Intelligence
Source: https://www.prnewswire.com/news-releases/oxipital-ai-closes-series-a-following-major-commercial-expansion-and-rapid-adoption-of-its-v-cortx-ai-vision-platform-302820784.html